MORE►
machine learning
Left: Michael Pusateri, CEO and Founder of Siepe; Right: Mark Schultis, the new president of Siepe [Photos: LinkedIn]
Amid ‘Private Credit Boom,’ Dallas Fintech Siepe Lands $30M Series B to Expand Tech-Enabled Solutions
by Lance Murray | Aug 22, 2024
"The new capital will help us continue our momentum in deploying integrated solutions and best-in-class service for fund managers in the private credit and broadly syndicated bank debt sector," Siepe CEO and founder Michael Pusateri said. In conjunction with the new funding, Siepe has appointed Mark Schultis as president.
by Lance Murray |
Dec 6, 2023
UT Arlington principal investigator Dr. Suvra Pal said that previous studies modeling the probability of a cancer cure—also called the cure rate—"used a generalized linear model." The new statistical modeling method published by Pal and his student is said to be 30% more effective in predicting who will be cured of cancer and who will need further treatment.
MORE►
by Lance Murray |
Nov 9, 2023
Save the Elephants will deploy a small fleet of drones equipped with high resolution and infrared cameras to capture elephant behavioral data, which will then be processed by Colossal’s machine learning core to develop algorithms that will label elephants and automatically identify individual and collective social behavior.
MORE►
by Quincy Preston |
Sep 30, 2023
The Techstars program pumped up the volume in its second year, reviewing more than 3,500 applications—four times more than last year. Founders from around the world will travel to Fort Worth for the "one-of-a-kind," whole health-focused program.
MORE►
[RobotLAB video screenshot]
RobotLAB Expands Lineup for ‘AI, Robotics & the Future of Work’ Summit at Its New Southlake HQ
by Lance Murray | Jul 10, 2023
RobotLAB CEO and Founder Elad Inbar says the summit will shed light on the advantages that robotics and AI bring to various industries. And lunch will be served on robots.
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Lance Murray |
May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
MORE►
by Lance Murray |
Mar 28, 2023
The Southlake-based company says retailers can sign up and use what it calls the industry's most powerful, accurate AI and ML-driven metric forecasting through a fully automated self-serve platform—all at no obligation. "We're confident retailers will be intrigued and delighted when they compare our automated forecast results with their actuals and legacy forecasts," says Founder and CEO Purna Mishra.
MORE►
Caris Life Sciences' new liquid biopsy lab in Phoenix. [Photo: Caris Life Sciences]
Irving’s Caris Life Sciences Closes On $400M Secured Term Loan
by Lance Murray | Jan 23, 2023
Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion.
Caris, a molecular science and technology company that is actively developing and delivering innovative solutions to revolutionize healthcare, said it will use the proceeds to repay debt, improve its unique precision medicine platform, and for general corporate purposes....
MORE►
by Quincy Preston |
Dec 22, 2022
The Dallas-based biopharmaceutical company expects to begin testing the drug candidate in a “first in human” trial in mid-2023. The drug was developed using the publicly traded company’s AI/ML drug development platform.
Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used to find new indications for cancer drugs in record times with significant reductions in costs.
Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used to find new indications for cancer drugs in record times with significant reductions in costs.
MORE►
![From left: Abidali Neemuchwala and Dayakar Puskoor [Photo: Dallas Venture Capital]](https://s24806.pcdn.co/wp-content/uploads/2022/05/DVC-Abidali-Neemuchwala-DayakarPuskoor-360x203.jpg)
by Kevin Cummings |
May 25, 2022
Dallas Venture Capital is "poised to bootstrap two large start-up ecosystems in the U.S. and India," says co-founder Dayakar Puskoor.
The venture firm—which has an office in Irving and another in Hyperabad, India—plans a combined deployment of the funds over four to five years.
The venture firm—which has an office in Irving and another in Hyperabad, India—plans a combined deployment of the funds over four to five years.
MORE►
by Kevin Cummings |
May 11, 2022
Dallas-based software startup HireLogic aims to improve the job interview process with its AI- and machine learning-powered platform, designed to help automate the screening process. Its CEO says he wants to help companies "gain insights from interview data to make faster, better hiring decisions."
MORE►
Chithrai Mani [Digit7]
New Spinoff Company Aims to Create Digital Solutions with ‘Next-Gen’ Technology
by Kevin Cummings | Mar 23, 2022
InfoVision, a Richardson-based digital transformation and consulting firm, is spinning out its Digit7 business—which focuses on developing customizable and scalable digital solutions through “next-gen” tech—as an independent entity.
Last year, Digit7 set up a 15,000 square-foot “innovation lab” in Richardson. The company also has offices in India.
Last year, Digit7 set up a 15,000 square-foot “innovation lab” in Richardson. The company also has offices in India.
MORE►
by David Seeley |
Feb 22, 2022
The study by a team of SMU civil engineering researchers was supported by a five-year, $584,000 National Science Foundation grant. The team hopes that their study will lead to equitable improvements in the identified neighborhoods—with better groceries, internet access, noise walls, crosswalks, hospital access, bike trails, and more.
MORE►
by Kevin Cummings |
Feb 16, 2022
New York-based Bowery Farming is a vertical farming startup that aims to lead "the next generation of agriculture." Valued at $2.3 billion and backed by Alphabet's VC investment arm GV, it will create 100 jobs at its new indoor farm in Arlington—where software, sensors, and machine learning will help things grow.
MORE►
by Kevin Cummings |
Feb 7, 2022
McKinney-based BALANCED Media|Technology, SMU, and the Retina Foundation of the Southwest are collaborating to commercialize technology to fight age-related macular degeneration.
Using a crowdsourced video game, players help the team create new data sets out of captured retinal images, helping to lead to potential breakthroughs in detection and treatment.
MORE►
